Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. 

Biotechnology

Aurion Biotech

Aurion Biotech's headquarters in Seattle, WA, United States

Pranay Khare

Arnaud Lacoste, PhD MBA

Xin Qu

Don Munoz

Saba Kadlec

Judith Mcgarry

Gwen Anderson

Hiromi Urasawa

Sterling Chung

Christy Faull

Katherine McMurry

Eris Jordan

Andrew Torres

Kazuya Inoue

Lan le

Arnaud Lacoste

Wendy Bliss

Edward Rangel

Brad Andrew Shutzberg

Edward Holland

Nicole Fram

Terry Kim

Elizabeth Yeu

William Link

Richard Lindstrom

Christine Z. McCauley

Andrew Elbardissi

Patrick Lally

Shigeru Kinoshita

Marjan Farid

Tom Frinzi

Eric Donnenfeld

John Berdahl

Jose L. Güell

Matthew Giegengack

The Finance and Business Administration team at Aurion Biotech is responsible for overseeing the company's financial planning, budgeting, and financial reporting, ensuring optimal resource allocation to support the development of transformative therapies. This team also manages administrative functions, real estate, and safety management, playing a crucial role in risk assessment and compliance, while driving strategic growth initiatives through business development efforts.

Finance and Business Administration

The Advisory Team at Aurion Biotech consists of industry experts who provide strategic guidance and insights to enhance the company's research and development efforts. They leverage their extensive experience in biotech and ophthalmology to evaluate clinical programs, recommend best practices, and support decision-making processes aimed at advancing innovative therapies to cure blindness.

Advisory Team

The Research and Development team at Aurion Biotech is dedicated to advancing innovative therapies aimed at curing blindness. This team, comprised of expert scientists and engineers, focuses on developing and optimizing cell therapy processes, conducting nonclinical studies, and ensuring robust analytical methods to support the company’s transformational platform. Their collaborative efforts drive the research pipeline, ultimately bringing new treatments from the lab to clinical application.

Research and Development

The Leadership Team at Aurion Biotech is responsible for setting the strategic direction and vision of the company. This team, comprised of executives from key functional areas such as clinical affairs, finance, marketing, and manufacturing, collaborates to drive the development of advanced therapies for blindness, ensuring alignment across initiatives and effective resource allocation to accelerate clinical progress and market readiness.

Leadership Team

The Clinical Development Team at Aurion Biotech is responsible for designing, implementing, and overseeing clinical trials to evaluate the safety and efficacy of their innovative therapies aimed at curing blindness. Comprising experts in analytical development, project management, and medical affairs, the team collaborates closely to ensure compliance with regulatory standards and to facilitate seamless communication between the company and clinical sites. Their efforts are critical in advancing Aurion Biotech's mission to transform the treatment landscape for vision loss.

Clinical Development Team

The Regulatory and Quality Assurance team at Aurion Biotech is responsible for ensuring that all advanced therapies meet stringent regulatory standards and quality benchmarks before reaching clinical application. This team oversees compliance with industry regulations, manages quality control processes, and coordinates with various departments to ensure that therapeutic developments align with safety and efficacy requirements essential for treating blindness.

Regulatory and Quality Assurance

Aurion Biotech

Org chart

Board & advisors

Teams